Sign in to view content

Randomized Trial of Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: 5-Year Outcomes

Jeffrey G. Gross, MD, FASRS

Video
Published 2018

Related

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter A. Campochiaro, MD
Annual Meeting Talks
2020
Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
Updates from the Field
2017
Impact of Retinal Ischemia on Visual Acuity Outcomes
Michael Peter Fielden, MD, FRCS(C)
Updates from the Field
2016

Category: Diabetic Retinopathy

See more